Media Type: Press Release

Filter

Thought Leadership

Product

Organization

NantHealth
NantHealth to Report 2019 Fourth-Quarter Financial Results and...
Culver City, Calif. – February 24, 2020: NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that...
NantHealth
NantHealth
NantOmics and NantHealth Announce Results of Proprietary Machine...
Study Published In Breast Cancer Research Shows How Deep-Learning Of Over 650 Breast Cancer Digital Pathology Images And Omics Data...
NantHealth
NantHealth
NantHealth and NantOmics Announce GPS Cancer® Platform May...
Findings Presented at the ASCO-SITC 2020 Clinical Immuno-Oncology Symposium Orlando, FL and Culver City, CA – February 19, 2020 –...
NantHealth
NantHealth
NantHealth Completes Sale of Connected Care Business to...
Culver City, CA – February 4, 2020: NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare technology company, today announced it...
NantHealth
NantHealth
NantHealth and NantOmics Reveal a Novel AI Based...
Derived from deep-learning models, the findings demonstrate novel AI methods of identifying tumor-infiltrating lymphocytes (TILs) in lung cancers Burlingame, CA...
NantHealth
NaviNet Open
The Health Plan Serving over 200,000 Covered Lives...
New Partnership to Enable Cost Savings and Rapid ROI Across the Continuum of Care Wheeling, WV & Culver City, CA –...
NaviNet Open
Eviti Connect
NantHealth’s Eviti Connect Data Shows Recycling of Chemotherapy...
NantHealth Presented These Findings at the ASCO 2020 Gastrointestinal Cancers Symposium San Francisco, CA – January 25, 2020: NantHealth, Inc....
Eviti Connect
Precision Insights
Data from NantHealth’s GPS Cancer platform reveals increased...
NantHealth Presented These Findings at the ASCO 2020 Gastrointestinal Cancers Symposium San Francisco, CA – January 25, 2020: NantHealth, Inc....
Precision Insights
NantHealth
Masimo to Acquire Connected Care Business from NantHealth
Irvine and Culver City, California — January 14, 2020: Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies, and NantHealth,...
NantHealth
Precision Insights
NantHealth Presents Research Demonstrating Real World Evidence of...
Eviti Connect study showed an increase in clinical uptake of practice-changing data San Antonio, TX – December 11, 2019 –...
Precision Insights
Precision Insights
NantHealth Announces FDA Marketing Authorization of Omics CoreSM:...
Landmark FDA clearance of whole exome sequencing in vitro diagnostic (IVD) test reporting overall tumor mutation burden (TMB) by sequencing...
Precision Insights
NantHealth
NantHealth Reports 2019 Third-Quarter Financial Results
Q3 Financial Highlights: Total revenue was $22.4 million SaaS revenue was $18.3 million, up 15% from Q3 2018 Total gross...
NantHealth